ONCOLYS BIOPHARMA INC.

Transcripts Oncolys BioPharma Inc.

Equities

4588

JP3202170001

Market Closed - Japan Exchange Other stock markets 07:00:00 24/05/2024 BST			5-day change	1st Jan Change
649 ^JPY	+4.85%		-0.92%	+14.46%

02-09	Oncolys BioPharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-07	Medigen Biotechnology Corp. Announces Signing of the Sales Cooperation Agreement for the New Drug OBP-301 in Japan	CI

Transcripts

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Oncolys BioPharma Inc. Provides Earning Guidance for the Year Ending December 31, 2022	05/08/22	CI
Oncolys BioPharma Inc. Provides Earning Guidance for the Year Ending December 31, 2022	13/05/22	CI
Oncolys Biopharma Inc. Provides Earning Guidance for the Year Ending December 31, 2022	10/02/22	CI
Oncolys BioPharma Inc. Provides Earnings Guidance for the Year Ending December 2021	05/11/21	CI
Oncolys Biopharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	07/05/21	CI
Oncolys BioPharma Inc. Provides Earnings Guidance for the Year Ending December 31, 2021	12/02/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer